Covid-19 CoronaVirus Information and Travel Information related to Covid-19 for travel to Indonesia, Asia and world Travel.
Showing posts with label Covid-19. Show all posts
Showing posts with label Covid-19. Show all posts
Sunday, February 6, 2022
Monday, January 3, 2022
Sunday, October 24, 2021
Tuesday, June 8, 2021
Saturday, March 20, 2021
Covid Vaccine comparison
Covid Vaccine comparison: Pfizer, Moderna, AstraZeneca, Sinopharm, Sinovac, Gamaleya, J&J
Source: South China Morning Post
#IndonesiaTaste
#IndonesiaAsiaTravel
#IndoChicago
Wednesday, January 27, 2021
Saturday, January 23, 2021
How has WHO responded to COVID-19
How has WHO responded to COVID-19
World Health Organization (WHO)
More information: http://www.who.int/COVID-19
How long does immunity against the coronavirus last? | COVID-19 Special
How long does immunity against the coronavirus last? | COVID-19 Special
Source: https://youtu.be/GuxkNSCWOxg
Friday, January 22, 2021
COVID-19 treatment(s) given to Trump
8 drugs Trump has been given for his COVID-19 treatment
Monday, October 5th, 2020
Since President Donald Trump tested positive for COVID-19 Oct. 1, he has been given a variety of drugs intended to shorten his recovery time and ease symptoms.
Though no drug has been FDA approved to treat the virus, a handful have shown positive results in clinical trials. The president has been given drugs that are being tested in clinical trials and aren't available to the general public.
The eight drugs the president reportedly has been given:
Dexamethasone — President Trump was prescribed the steroid dexamethasone, a drug commonly used to treat asthma, rheumatoid arthritis and certain cancer, on Oct. 3. Sean Conley, DO, the president's physician, said the steroid was given to him in response to his blood oxygen levels dropping twice to 93 percent, according to STAT.
The steroid is typically recommended for hospitalized patients who need oxygen or are on ventilators. A study released in June showed that dexamethasone reduced deaths by one-third for those who had been sick for more than a week and were on mechanical ventilators, but had no impact on patients receiving no respiratory support. The study suggested that the drug may do more harm than good for patients with milder COVID-19 cases, since steroids hamper the body's immune system.
The drug is typically given to patients with severe COVID-19 to prevent an immune system overreaction. Some experts called it a "major breakthrough" for COVID-19 treatment, as it was the first drug shown to improve survival rates.
Remdesivir — President Trump was given his first dose of remdesivir Oct. 2, and he will be given a five-day course, CNN reported. Remdesivir, made by Gilead (who gave it the brand name of Veklury), was granted emergency use authorization by the FDA on May 1 after a study showed it caused a 31 percent faster recovery time compared to a placebo.
Remdesivir is an intravenous drug that works by targeting the system coronaviruses use to replicate themselves. It has been previously tested for Ebola, but hasn't been officially approved in any country. The FDA expanded its emergency use authorization for remdesivir Aug. 28, allowing it to be used on all hospitalized patients. It had previously only been authorized for those on ventilators or with low blood oxygen levels.
Regeneron's monoclonal antibody — On Oct. 2, the White House released a letter saying the president received a single 8-gram dose of Regeneron's monoclonal antibody cocktail, called REGN-COV2, the highest dose of the drug being tested in late-stage clinical trials, according to Politico.
Regeneron said in a Sept. 29 news release that a high dose of the drug caused the level of the virus to decrease in patients in an early clinical trial, indicating it may help COVID-19 patients recover faster. The trial seemed to show the drug had a bigger effect on patients who were infected with the virus but hadn't created high levels of their own antibodies against the virus. The drug uses synthetic versions of the antibodies patients' bodies create when they recover from a disease. In July, Regeneron received $450 million from Operation Warp Speed, the White House's task force to expedite COVID-19 vaccine development, to manufacture thousands of doses of the drug.
Regeneron CEO Leonard Schleifer, MD, PhD, told The New York Times that President Trump's medical staff reached out to the company for permission to use the drug, and that it was cleared with the FDA. Mr. Schleifer has known the president casually for many years and is a member of his golf club in Westchester County, N.Y., according to the Times.
Zinc — President Trump also has been given zinc, according to the Times, which helps the immune system fight outside bacteria and viruses. Zinc is an essential mineral that is naturally present in some foods and is available as a dietary supplement. There is no evidence that zinc helps fight COVID-19, and the FDA has issued warning letters to some companies that have tried to claim there's a link between zinc products and reduced risk of COVID-19.
Vitamin D — President Trump has been given vitamin D, the Times reported, which is good for bone health. There is no evidence vitamin D directly reduces the risk of COVID-19, and the FDA has sent warning letters to companies trying to sell vitamin D products as COVID-19 treatments. Vitamin D can also help reduce inflammation, according to the National Institutes of Health.
Famotidine — The generic name for Pepcid, famotidine is commonly used to treat ulcers, heartburn, indigestion and reduces the amount of acid in the stomach. A clinical trial testing the drug in hospitalized COVID-19 patients in New York wasn't able to recruit enough patients to properly evaluate its impact, according to Science.
Melatonin — Commonly used to treat insomnia, some studies have suggested that melatonin could also help COVID-19 patients with diabetes and obesity, according to CNN.
"The ability of melatonin to decrease viral infections in obese and diabetic patients is attributed to its characterists, such as potent antioxidant effects, improving the endogenous antioxidant system, immunomodulatory, and the strong anti-inflammatory capability," according to researchers from Mansoura University in Egypt.
A health summary for President Trump released in June showed that he was obese, at 244 pounds, the Times reported.
Aspirin — Commonly given to older patients to prevent heart disease, aspirin is also a popular painkiller. It can reduce the risk of blood-clotting, and evidence has shown COVID-19 can trigger blood clots in some patients. The president has mild heart disease, the Times reported.
Thursday, January 21, 2021
CoronaVirus Info - Covid-19
- Covid19 Health Center / TESTING Center
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization
- Imigrasi Indonesia - Travel during Covid
- Kementerian Kesehatan Indonesia - Covid
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
- Apply for a Visa to visit Indonesia
Sunday, December 13, 2020
Long Covid: When coronavirus symptoms don't go away | DW News
- Covid19 Health Center / TESTING Center
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
Coronavirus Update 118: AstraZeneca DNA COVID 19 Vaccine Explained (vs. ...
Coronavirus Update 118: AstraZeneca DNA COVID 19 Vaccine Explained (vs. Pfizer / BioNTech, Moderna)
- Covid19 Health Center / TESTING Center
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
Saturday, December 12, 2020
Vitamin D and COVID 19: The Evidence for Prevention and Treatment of Cor...
If you choose to take vitamin D supplements, 10 micrograms a day will be enough for most people. Do not take more than 100 micrograms (4,000 IU) of vitamin D a day as it could be harmful. This applies to adults, including pregnant and breastfeeding women and the elderly, and children aged 11 to 17 years.
Source: https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/
- Covid19 Health Center / TESTING Center
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
Decoding COVID-19 | NOVA | PBS
Decoding COVID-19
NOVA | PBS
- Covid19 Health Center / TESTING Center
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
Monday, June 29, 2020
IATA COVID-19 Travel Regulations Map
COVID-19 Travel Regulations Map
Notice to Visa Applicants Re COVID-19
Please find the news update from Directorate General of Immigration of the Republic of Indonesia as of July 13, 2020 here
PROVISIONAL PROHIBITIONS OF FOREIGNERS ENTERING INDONESIAN TERRITORY RELATED TO COVID-19
The Government of the Republic of Indonesia has issued a new decree in response to the escalating COVID 19 outbreak.
Effective from April 2, 2020, Indonesia will refuse entries to foreigners (visiting or transiting).
This decree exempts the following:
For exempted foreigners, the following are required:
NOTE:
* While waiting for the test result of PCR, foreigner(s) must undergo quarantine at hotel designated by Indonesian Authorities. Lodging and meal expenses shall be borne by the foreigner(s) and/or the employer(s)
COVID-19 Travel Regulations Map* (powered by Timatic)
02 August 2020 00:00:06 UTC
Published 10.07.2020
1. Passengers are not allowed to enter and transit.
- This does not apply to nationals of Indonesia.
- This does not apply to passengers with a Temporary Stay Permit (ITAS) or Permanent Stay Permit (ITAP).
- This does not apply to passengers with a diplomatic or a service visa.
- This does not apply to passengers with a diplomatic or service stay permit.
- This does not apply to passengers with a visa issued after 31 March 2020.
2. Passengers and airline crew must have a medical certificate with a negative Coronavirus (COVID-19) PCR test result issued at most 7 days before arrival.
3. Passengers without a medical certificate with a negative Coronavirus (COVID-19) PCR test result are subject to medical screening and quarantine for 14 days.
4. Airline crew without a medical certificate with a negative Coronavirus (COVID-19) PCR test result are subject to medical screening and quarantine until their next flight.
5. Deadhead crew will be given an entry stamp. They must:
- have a valid crew ID card or crew member certificate;
- provide written notification to Immigration Officer proving they will be on duty on the return flight. The notification must be received by Immigration Officer minimum 24 hours from arrival.
1. Passengers are not allowed to enter and transit.
- This does not apply to nationals of Indonesia.
- This does not apply to passengers with a Temporary Stay Permit (ITAS) or Permanent Stay Permit (ITAP).
- This does not apply to passengers with a diplomatic or a service visa.
- This does not apply to passengers with a diplomatic or service stay permit.
- This does not apply to passengers with a visa issued after 31 March 2020.
2. Passengers and airline crew must have a medical certificate with a negative Coronavirus (COVID-19) PCR test result issued at most 7 days before arrival.
3. Passengers without a medical certificate with a negative Coronavirus (COVID-19) PCR test result are subject to medical screening and quarantine for 14 days.
4. Airline crew without a medical certificate with a negative Coronavirus (COVID-19) PCR test result are subject to medical screening and quarantine until their next flight.
5. Deadhead crew will be given an entry stamp. They must:
- have a valid crew ID card or crew member certificate;
- provide written notification to Immigration Officer proving they will be on duty on the return flight. The notification must be received by Immigration Officer minimum 24 hours from arrival.
Notice to Visa Applicants Re COVID-19
Please find the news update from Directorate General of Immigration of the Republic of Indonesia as of July 13, 2020 here
PROVISIONAL PROHIBITIONS OF FOREIGNERS ENTERING INDONESIAN TERRITORY RELATED TO COVID-19
The Government of the Republic of Indonesia has issued a new decree in response to the escalating COVID 19 outbreak.
Effective from April 2, 2020, Indonesia will refuse entries to foreigners (visiting or transiting).
This decree exempts the following:
- Holders of KITAS (Limited Stay Permit) and KITAP (Permanent Stay Permit)
- Holders of Diplomatic/Service visa
- Holders of Diplomatic Stay Permit/ Service Stay Permit
- Medical, Food, and Humanitarian Aid Support Workers
- Transportation Crew
- Employee/workers of National Strategic Projects (such as infrastructure and construction)
For exempted foreigners, the following are required:
- Health certificate or letter written in English stating a negative COVID-19 result based on a PCR test. Foreigners who are unable to provide the aforementioned Health certificate/letter will be required to undergo a PCR test at designated place *
- Has established a minimum of 14 (fourteen) days residence in countries deemed clear of COVID-19
- Must be willing to follow the 14 (fourteen) days quarantine, as mandated by the Government of the Republic of Indonesia
- If must apply for visa, applications are by mail only
NOTE:
* While waiting for the test result of PCR, foreigner(s) must undergo quarantine at hotel designated by Indonesian Authorities. Lodging and meal expenses shall be borne by the foreigner(s) and/or the employer(s)
Monday, June 1, 2020
CoronaVirus Covid-19 Info
CoronaVirus Info - Covid19
- Covid19 Health Center / TESTING Center
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization (Main page)
- WHO Advice for Public
- WHO Open Courses
- World O Meter (Map and Statistic)
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- Informasi Covid-19 (Bahasa Indonesia)
- Chicago Area School Emergency Closing Center
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
Chicago Info and News
- Chicago Info
- Chicago Tourism
- Chicago Tribune-Newspaper
- Daily Herald-Chicago-suburb paper
- Chicago Weather
- Aljazeera News
- BBC News
- CNN World News
- KOMPAS News
- NPR News
- Reuters News
- Time News
World News
Subscribe to:
Posts (Atom)
Are you travelling to Indonesia ?
Indonesian Events in Chicago: IndoChicago Taste of Indonesia Events in USA Ticket Pulang Kampung: Hubungi Tedjo Express Travel/ or Ind...
-
Indonesia Travel Restrictions Updated on July 22, 2021 as per the Minister of Law and Human Rights Regulation No. 27/2021. Entry Requireme...
-
How long does immunity against the coronavirus last? | COVID-19 Special Source: https://youtu.be/GuxkNSCWOxg
-
Coronavirus Update 118: AstraZeneca DNA COVID 19 Vaccine Explained (vs. Pfizer / BioNTech, Moderna) Indonesian Events in Chicago: IndoC...







